Krankenhaus Porz Am Rhein gGmbH — Clinical Trial Site

10 Registered trials

7 Currently recruiting

Organisation

Krankenhaus Porz Am Rhein gGmbH

Location

Cologne, Germany

Identifier

ORG-100024223

Address

Urbacher Weg 19, Porz, 51149, Germany

Departments

#40716: Rheumatologie
#40716:Rheumatologie
Department of Rheumatology
Klinik fuer Rheumatologie
Klinik fuer Rheumatologie, Rheumaambulanz / 5. Etage
Klinik für Rheumatologie
Rheumatologie
Rheumatology

Clinical trials at this site (10)

Search interface

A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis Recruiting

2025-520721-21-00 Rheumatoid Arthritis 4 2025-10-20
A Randomized, Placebo-controlled, Double-blind, Multicenter Phase 3 Protocol to Assess the Efficacy and Safety of Nipocalimab in Adults with… Recruiting

2024-513965-38-01 Sjögren's Disease 5 2025-06-16
Study of GS-0151 in Participants With Rheumatoid Arthritis Recruiting

2024-516520-34-00 Rheumatoid Arthritis 3 2025-11-17
A study to test whether nerandomilast helps people with lung fibrosis related to rheumatic diseases Recruiting

2024-512849-17-00 Systemic Autoimmune Rheumatic Diseases associated Inter 5 2025-11-14
A study to learn if dapirolizumab pegol works and is safe in people with moderately to severely active systemic lupus erythematosus (SLE) Recruiting

2023-508191-11-00 Systemic lupus erythematosus (SLE) 5 2024-11-28
Prospective, multicentre, open-label clinical trial on the effect of GUSelkumab on the resolution of ultrasound-proven ENThEsitis in patient… Recruiting

2024-512459-19-00 Psoriatic arthritis 6 2024-09-13
A study of the efficacy and safety of belimumab compared to placebo in adults with systemic sclerosis-associated interstitial lung disease. Recruiting

2023-503219-14-01 systemic sclerosis associated interstitial lung disease 10 2024-05-22
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic … Ended

2023-503655-10-00 Systemic Lupus Erythematosus (SLE). 5 2023-11-20
A study to learn if dapirolizumab pegol is safe and works long-term in people with systemic lupus erythematosus Ended

2023-506368-14-00 Systemic lupus erythematosus (SLE) 5 2021-09-07
Efficacy and Safety of secukinumab in patients with new onset of giant cell arteritis who are in clinical remission Ended

2024-512856-40-00 Giant Cell Arteritis 5 2022-09-21